Skip to main content

Ethicon Pelvic Mesh Trial Concludes With $41 Million Verdict

Ethicon Pelvic Mesh Trial Concludes With $41 Million Verdict

Ethicon Pelvic Mesh Trial Concludes With $41 Million Verdict

Introduction

On Thursday, January 31, a Philadelphia jury ordered Johnson & Johnson's Ethicon subsidiary to pay $41 million to the plaintiff in a product liability lawsuit involving Gynemesh, Prolift, and TVT-O meshes.

The lawsuit was brought by a 57-year old plaintiff who went through surgery after surgery to get rid of the discomfort, infections, and other painful complications caused by the vaginal mesh.  In May 2007, she was implanted with Prolift pelvic mesh to treat pelvic organ prolapse, and in subsequent years she was implanted with a TVT-O mesh to treat incontinence, and a Gynemesh to fix pelvic floor disorders. According to the lawsuit, these surgeries proved to be a nightmare for the woman, as well as several other women who experienced similar complications due to the device's high failure rate and irreversible side-effects. The plaintiff's attorneys told, “this jury rightfully compensated one of the thousands of Johnson & Johnson victims terribly injured by its mesh products and sent a strong deterrent message through its punitive damages verdict.” The verdict includes $25 million in punitive damages, $15 million in compensation, and $1 million to the plaintiff's husband for the loss of consortium.

J&J faces about 37,400 lawsuits related to defective pelvic mesh complications. Ethicon Pelvic Mesh lawsuits are consolidated as a part of a multidistrict litigation (MDL No. 2327; In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) overlooked by U.S. District Judge Joseph R. Goodwin in the Southern District of West Virginia.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!